Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
8.02 USD | +1.13% | +1.39% | -24.84% |
04-17 | Morgan Stanley Trims Price Target on WalkMe to $11 From $12, Keeps Equalweight Rating | MT |
04-15 | Barclays Adjusts Price Target on WalkMe to $8.50 From $10, Maintains Underweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.84% | 729M | |
-19.41% | 26.53B | |
+2.38% | 9.32B | |
-0.35% | 4.6B | |
+2.13% | 479M | |
-8.48% | 273M | |
-20.84% | 210M | |
-38.85% | 189M | |
-4.81% | 152M | |
-39.05% | 149M |
- Stock Market
- Equities
- WKME Stock
- News WalkMe Ltd.
- BMO Capital Trims Price Target on WalkMe to $10.50 From $14, Maintains Outperform Rating